The Sam and Ann Barshop Institute for Longevity and Aging Studies at UT Health San Antonio is one of the world’s premier institutes dedicated to age-related diseases and is the only aging-intensive research institute in the country to have four designations. Barshop Institute’s mission in understanding the basic biology of aging and discovering therapies that will treat and cure debilitating aging diseases.
The Barshop Institute supports its predoctoral and postdoctoral trainees in part through the Biology of Aging Training Program (T32). This program allows them to design, conduct and present their research to those focused on aging research.
UT Health San Antonio partners with the U.S. Department of Veterans Affairs Geriatric Research, Education and Clinical Center (GRECC) at the Audie L. Murphy Memorial VA Hospital to initiate clinical trials to further advanced knowledge of age-related diseases and provide preventive solutions.
Two National Institute on Aging-funded centers: Nathan Shock and Claude D. Pepper
NIA-sponsored Interventions Testing Program site
U.S. Department of Veterans Affairs Geriatric Research, Education and Clinical Center (GRECC)
In The News
The BioFest Days brought the community together April 7, for an evening of discovery and connection at the UT Health San Antonio Center for Brain Health. Hosted as part of the 12-day, citywide celebration of biomedical advancement organized by BioMed SA, the event invited attendees to explore how research, clinical care and community involvement […]
New UT San Antonio study introduces analytical tool to better hone aging interventions When scientists test potential life‑extending interventions, often the central question simply asks if the intervention works. New research from The University of Texas at San Antonio (UT San Antonio) suggests that the more meaningful questions may be when does it work […]
A drug once known almost exclusively for preventing organ transplant rejection is now at the center of a National Institute on Aging-funded clinical study at UT Health San Antonio, to determine how rapamycin should be used in older adults to promote healthy aging.